Further reading Phase II trial gives hope for pancreatic cancer The findings of a phase II randomised trial, published in Nature Medicine , has shown elraglusib, combined with chemotherapy, doubles survival after one year in patients with pancreatic cancer and reduces the risk of death by 38%
Advances in antibody-based therapy in oncology
Absorption may be a problem, same as with birth-control pills, he says
Overall adherence to the Dietary Guidelines for Americans is associated with reduced prevalence of early age-related nuclear lens opacities in women
Schedule your donation appointment when you're feeling well and have eaten a balanced meal within the past 3 hours
References Iranmanesh A, Lizarralde G, Veldhuis JD